Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.53
+0.28 (4.40%)
Aug 10, 2026, 11:44 AM EDT - Market open
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.85B in the quarter ending June 30, 2026, with 12.73% growth. This brings the company's revenue in the last twelve months to $12.20B, up 10.47% year-over-year. In the year 2025, Bausch Health Companies had annual revenue of $10.27B with 6.66% growth.
Revenue (ttm)
$12.20B
Revenue Growth
+10.47%
P/S Ratio
0.22
Revenue / Employee
$534,631
Employees
20,300
Market Cap
2.44B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.27B | 641.00M | 6.66% |
| Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
| Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
| Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
| Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
| Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
| Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
| Dec 31, 2018 | 8.38B | -344.00M | -3.94% |
| Dec 31, 2017 | 8.72B | -950.00M | -9.82% |
| Dec 31, 2016 | 9.67B | -773.00M | -7.40% |
| Dec 31, 2015 | 10.45B | 2.24B | 27.31% |
| Dec 31, 2014 | 8.21B | 2.44B | 42.23% |
| Dec 31, 2013 | 5.77B | 2.29B | 65.77% |
| Dec 31, 2012 | 3.48B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.14B |
| Trulieve Cannabis | 1.14B |
| Prestige Consumer Healthcare | 1.10B |
| ANI Pharmaceuticals | 978.38M |
| BioCryst Pharmaceuticals | 940.61M |
| Supernus Pharmaceuticals | 830.44M |
| HUTCHMED (China) | 549.12M |
| Xeris Biopharma Holdings | 335.41M |
BHC News
- 4 days ago - Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board - PRNewsWire
- 11 days ago - Bausch Health Companies Earnings Call Transcript: Q2 2026 - Transcripts
- 11 days ago - Bausch Health Companies Earnings release: Q2 2026 - Filings
- 11 days ago - Bausch Health Companies Slides: Q2 2026 - Filings
- 11 days ago - Bausch Health Companies Quarterly report: Q2 2026 - Filings
- 11 days ago - Bausch Health reports Q2 non-GAAP EPS $1.26, consensus $1.01 - TheFly
- 11 days ago - BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE - PRNewsWire
- 4 weeks ago - Bausch to stop glaucoma eye drop development after trial miss - Reuters